Fibrocell Science, Inc. ( FCSC ) was a big mover last session with its shares rising over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 57% in the past one-month time frame.
This autologous cell therapy company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn't been in trend either. Friday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Fibrocell Science currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may, however, consider Actelion Ltd. ( ALIOF ) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report